Cravatex Board Meeting Scheduled on May 15, 2026 to Consider FY26 Audited Results and Dividend Recommendation
Cravatex Limited has scheduled a Board of Directors meeting on May 15, 2026, to consider audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board will also deliberate on the recommendation of a final dividend on equity shares for FY26, if any. The intimation was filed with BSE on May 7, 2026, under Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

*this image is generated using AI for illustrative purposes only.
Cravatex Limited has informed BSE of an upcoming Board of Directors meeting, scheduled for Friday, May 15, 2026. The disclosure was made under Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was filed on May 7, 2026.
Board Meeting Agenda
The Board meeting has been convened to deliberate on two key matters pertaining to the company's financial performance and shareholder returns for the concluded fiscal year. The following items are on the agenda:
| Agenda Item: | Details |
|---|---|
| Financial Results: | Audited standalone & consolidated results for the quarter and financial year ended March 31, 2026 |
| Dividend Recommendation: | Recommendation of final dividend on equity shares for the financial year ended March 31, 2026, if any |
Regulatory Disclosure
The intimation was submitted to the Department of Corporate Services (DCS-Listing) at BSE Limited, Dalal Street, Mumbai. The filing was signed by Sudhanshu Namdeo, Company Secretary and Compliance Officer of Cravatex Limited, in compliance with applicable listing regulations.
Shareholders and market participants may note that the dividend recommendation, if any, will be subject to the Board's decision at the meeting scheduled on May 15, 2026.
Historical Stock Returns for Cravatex
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -2.51% | +2.78% | +2.78% | -10.74% | -13.76% | +29.98% |
How does Cravatex's expected financial performance for FY2026 compare to its previous fiscal year, and what revenue or profitability trends might influence the Board's dividend decision?
Given the competitive landscape in the branded apparel and footwear sector, how might Cravatex's FY2026 results reflect broader industry headwinds or tailwinds?
If Cravatex declares a final dividend, how would it compare to its historical dividend payout ratios, and what signal would it send about management's confidence in future cash flows?






























